350 related articles for article (PubMed ID: 20193106)
21. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
[TBL] [Abstract][Full Text] [Related]
22. Identification of a cancer stem-like population in the Lewis lung cancer cell line.
Zhang AM; Fan Y; Yao Q; Ma H; Lin S; Zhu CH; Wang XX; Liu J; Zhu B; Sun JG; Chen ZT
Asian Pac J Cancer Prev; 2012; 13(3):761-6. PubMed ID: 22631644
[TBL] [Abstract][Full Text] [Related]
23. [Identification and characterization of stem cells in an ovarian cancer cell line and examination their drug resistance].
Wei Z; Wang Y; Yu X; Zhang S
Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):452-7. PubMed ID: 26311554
[TBL] [Abstract][Full Text] [Related]
24. Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.
Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
Cell Mol Neurobiol; 2008 Nov; 28(7):991-1003. PubMed ID: 18350379
[TBL] [Abstract][Full Text] [Related]
25. A preliminary study of side population cells in human gastric cancer cell line HGC-27.
Gao G; Sun Z; Wenyong L; Dongxia Y; Zhao R; Zhang X
Ann Transplant; 2015 Mar; 20():147-53. PubMed ID: 25773762
[TBL] [Abstract][Full Text] [Related]
26. Endosialin‑expressing bone sarcoma stem‑like cells are highly tumor‑initiating and invasive.
Sun DX; Liao GJ; Liu KG; Jian H
Mol Med Rep; 2015 Oct; 12(4):5665-70. PubMed ID: 26300407
[TBL] [Abstract][Full Text] [Related]
27. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
[TBL] [Abstract][Full Text] [Related]
28. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer.
Nakamura M; Zhang X; Mizumoto Y; Maida Y; Bono Y; Takakura M; Kyo S
Int J Oncol; 2014 Mar; 44(3):669-77. PubMed ID: 24366104
[TBL] [Abstract][Full Text] [Related]
30. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
31. Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line.
Christgen M; Ballmaier M; Bruchhardt H; von Wasielewski R; Kreipe H; Lehmann U
Mol Cell Biochem; 2007 Dec; 306(1-2):201-12. PubMed ID: 17660947
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human endostatin could eliminate the pro-angiogenesis priority of SP cells sorted from non-small cell lung cancer cells.
Cao B; Jia J; Ma L; Di L; Song G; Yuan Y; Ma B; Zhu Y; Yu J; Wang X; Zhou X; Lyerly HK; Ren J
Clin Transl Oncol; 2012 Aug; 14(8):575-85. PubMed ID: 22855139
[TBL] [Abstract][Full Text] [Related]
33. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
[TBL] [Abstract][Full Text] [Related]
34. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
[TBL] [Abstract][Full Text] [Related]
35. CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist.
Sarvi S; Mackinnon AC; Avlonitis N; Bradley M; Rintoul RC; Rassl DM; Wang W; Forbes SJ; Gregory CD; Sethi T
Cancer Res; 2014 Mar; 74(5):1554-65. PubMed ID: 24436149
[TBL] [Abstract][Full Text] [Related]
36. Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling.
Hepburn AC; Veeratterapillay R; Williamson SC; El-Sherif A; Sahay N; Thomas HD; Mantilla A; Pickard RS; Robson CN; Heer R
PLoS One; 2012; 7(11):e50690. PubMed ID: 23226356
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
[TBL] [Abstract][Full Text] [Related]
38. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C
Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149
[TBL] [Abstract][Full Text] [Related]
39. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.
Chen YC; Hsu HS; Chen YW; Tsai TH; How CK; Wang CY; Hung SC; Chang YL; Tsai ML; Lee YY; Ku HH; Chiou SH
PLoS One; 2008 Jul; 3(7):e2637. PubMed ID: 18612434
[TBL] [Abstract][Full Text] [Related]
40. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
